843 related articles for article (PubMed ID: 11313012)
1. Natural history of murine gamma-herpesvirus infection.
Nash AA; Dutia BM; Stewart JP; Davison AJ
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
[TBL] [Abstract][Full Text] [Related]
2. Murine herpesvirus pathogenesis: a model for the analysis of molecular mechanisms of human gamma herpesvirus infections.
Rajćáni J; Kúdelová M
Acta Microbiol Immunol Hung; 2005; 52(1):41-71. PubMed ID: 15957234
[TBL] [Abstract][Full Text] [Related]
3. Requirement for CD4+ T cells in V beta 4+CD8+ T cell activation associated with latent murine gammaherpesvirus infection.
Flaño E; Woodland DL; Blackman MA
J Immunol; 1999 Sep; 163(6):3403-8. PubMed ID: 10477611
[TBL] [Abstract][Full Text] [Related]
4. A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells.
Tibbetts SA; Suarez F; Steed AL; Simmons JA; Virgin HW
Virology; 2006 Sep; 353(1):210-9. PubMed ID: 16797052
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the host response to a gamma-herpesvirus.
Doherty PC; Christensen JP; Belz GT; Stevenson PG; Sangster MY
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):581-93. PubMed ID: 11313013
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of mouse mammary glands to murine gammaherpesvirus 72 (MHV-72) infection: evidence of MHV-72 transmission via breast milk.
Raslova H; Berebbi M; Rajcani J; Sarasin A; Matis J; Kudelova M
Microb Pathog; 2001 Aug; 31(2):47-58. PubMed ID: 11453700
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection.
Aricò E; Robertson KA; Belardelli F; Ferrantini M; Nash AA
Vaccine; 2004 Mar; 22(11-12):1433-40. PubMed ID: 15063566
[TBL] [Abstract][Full Text] [Related]
8. Herpesvirus saimiri.
Fickenscher H; Fleckenstein B
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):545-67. PubMed ID: 11313011
[TBL] [Abstract][Full Text] [Related]
9. Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model.
El-Gogo S; Staib C; Meyr M; Erfle V; Sutter G; Adler H
Vaccine; 2007 May; 25(20):3934-45. PubMed ID: 17433507
[TBL] [Abstract][Full Text] [Related]
10. Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection.
Dutia BM; Allen DJ; Dyson H; Nash AA
Virology; 1999 Sep; 261(2):173-9. PubMed ID: 10497103
[TBL] [Abstract][Full Text] [Related]
11. Apparent MHC-independent stimulation of CD8+ T cells in vivo during latent murine gammaherpesvirus infection.
Coppola MA; Flaño E; Nguyen P; Hardy CL; Cardin RD; Shastri N; Woodland DL; Blackman MA
J Immunol; 1999 Aug; 163(3):1481-9. PubMed ID: 10415050
[TBL] [Abstract][Full Text] [Related]
12. CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFNgamma.
Sparks-Thissen RL; Braaten DC; Hildner K; Murphy TL; Murphy KM; Virgin HW
Virology; 2005 Aug; 338(2):201-8. PubMed ID: 15961135
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of a murine gammaherpesvirus infection immunocompromised mice.
Kulkarni AB; Holmes KL; Fredrickson TN; Hartley JW; Morse HC
In Vivo; 1997; 11(4):281-91. PubMed ID: 9292294
[TBL] [Abstract][Full Text] [Related]
14. MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68.
Aricò E; Monque DM; D'Agostino G; Moschella F; Venditti M; Kalinke U; Allen DJ; Stewart JP; Nash AA; Belardelli F; Ferrantini M
Vaccine; 2011 May; 29(23):3935-44. PubMed ID: 21481326
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
16. The art of survival during viral persistence.
Stohlman SA; Ramakrishna C; Tschen SI; Hinton DR; Bergmann CC
J Neurovirol; 2002 Dec; 8 Suppl 2():53-8. PubMed ID: 12491152
[TBL] [Abstract][Full Text] [Related]
17. Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68.
Sunil-Chandra NP; Arno J; Fazakerley J; Nash AA
Am J Pathol; 1994 Oct; 145(4):818-26. PubMed ID: 7943173
[TBL] [Abstract][Full Text] [Related]
18. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
19. K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus.
Stevenson PG; May JS; Smith XG; Marques S; Adler H; Koszinowski UH; Simas JP; Efstathiou S
Nat Immunol; 2002 Aug; 3(8):733-40. PubMed ID: 12101398
[TBL] [Abstract][Full Text] [Related]
20. Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice.
Usherwood EJ; Stewart JP; Robertson K; Allen DJ; Nash AA
J Gen Virol; 1996 Nov; 77 ( Pt 11)():2819-25. PubMed ID: 8922476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
